Neurology, ophthalmology, orl
Zeile 17: | Zeile 17: | ||
− | + | {{tp|p=32415003|t=2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?|pdf=|usr=007}} | |
− | + | {{tp|p=32490972|t=2020. COVID-19 and the eye: how much do we really know? A best evidence review.|pdf=|usr=007}} | |
− | + | {{tp|p=32443834|t=2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.|pdf=|usr=007}} | |
{{ttp|p=32348111|t=ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?|pdf=|usr=}} | {{ttp|p=32348111|t=ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?|pdf=|usr=}} | ||
{{tp|p=32322822|t=ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC |pdf=|usr=}} | {{tp|p=32322822|t=ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC |pdf=|usr=}} | ||
Zeile 28: | Zeile 28: | ||
{{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}} | {{tp|p=32232433|t=2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China |pdf=|usr=}} | ||
{{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}} | {{tp|p=32344366|t=2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report |pdf=|usr=}} | ||
− | + | {{tp|p=32478706|t=2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?|pdf=|usr=007}} | |
{{tp|p=32374367|t=ä. Delirium: a missing piece in the COVID-19 pandemic puzzle |pdf=|usr=}} | {{tp|p=32374367|t=ä. Delirium: a missing piece in the COVID-19 pandemic puzzle |pdf=|usr=}} | ||
{{tp|p=32333819|t=2020. COVID-19: what if the brain had a role in causing the deaths?|pdf=|usr=}} | {{tp|p=32333819|t=2020. COVID-19: what if the brain had a role in causing the deaths?|pdf=|usr=}} | ||
Zeile 37: | Zeile 37: | ||
{{ttp|p=32388138|t=2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |pdf=|usr=}} | {{ttp|p=32388138|t=2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |pdf=|usr=}} | ||
{{tp|p=32342265|t=ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome |pdf=|usr=}} | {{tp|p=32342265|t=ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome |pdf=|usr=}} | ||
+ | {{tp|p=32457227|t=2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.|pdf=|usr=007}} | ||
+ | {{tp|p=32390132|t=2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32482781|t=2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32461235|t=2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32444427|t=2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?|pdf=|usr=007}} | ||
+ | {{tp|p=32386285|t=2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.|pdf=|usr=007}} | ||
+ | {{tp|p=32352450|t=2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.|pdf=|usr=007}} | ||
+ | {{tp|p=32463395|t=2020. The involvement of the central nervous system in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32355007|t=2020. The mystery of the pandemic's 'happy hypoxia'.|pdf=|usr=007}} | ||
+ | {{tp|p=32286214|t=2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].|pdf=|usr=007}} | ||
+ | {{tp|p=32400371|t=2020. [Anosmia and ageusia as primary symptoms of COVID-19].|pdf=|usr=007}} | ||
+ | {{tp|p=32476394|t=2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32468632|t=2020. Olfactory dysfunction in recovered COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32512352|t=2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32442268|t=2020. Stroke in a young COVID -19 patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32484418|t=2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32437314|t=2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.|pdf=|usr=007}} | ||
+ | {{tp|p=32437313|t=2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32407258|t=2020. COVID-19-Associated Leukoencephalopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32510821|t=2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.|pdf=|usr=007}} | ||
+ | {{tp|p=32506730|t=2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32506662|t=2020. Necrotizing periodontal disease: oral manifestation of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32419568|t=2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32453685|t=2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32490966|t=2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32469246|t=2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32436441|t=2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.|pdf=|usr=007}} | ||
+ | {{tp|p=32423359|t=2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.|pdf=|usr=007}} | ||
+ | {{tp|p=32423285|t=2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.|pdf=|usr=007}} | ||
+ | {{tp|p=32502296|t=2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.|pdf=|usr=007}} | ||
+ | {{tp|p=32502289|t=2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.|pdf=|usr=007}} | ||
+ | {{tp|p=32348051|t=2020. Anosmie et COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32501861|t=2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32404789|t=2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.|pdf=|usr=007}} | ||
+ | {{tp|p=32468450|t=2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.|pdf=|usr=007}} | ||
+ | {{tp|p=32444493|t=2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32444492|t=2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.|pdf=|usr=007}} | ||
+ | {{tp|p=32439822|t=2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32439821|t=2020. Generalized myoclonus in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32487714|t=2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.|pdf=|usr=007}} | ||
+ | {{tp|p=32482845|t=2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.|pdf=|usr=007}} | ||
+ | {{tp|p=32424429|t=2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.|pdf=|usr=007}} | ||
+ | {{tp|p=32496534|t=2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32490520|t=2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.|pdf=|usr=007}} | ||
+ | {{ttp|p=32392566|t=2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.|pdf=|usr=007}} | ||
+ | {{tp|p=32487282|t=2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32445201|t=2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.|pdf=|usr=007}} | ||
+ | {{tp|p=32505222|t=2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.|pdf=|usr=007}} | ||
+ | {{tp|p=32503883|t=2020. Defining causality in COVID-19 and neurological disorders.|pdf=|usr=007}} | ||
+ | {{tp|p=32507577|t=2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.|pdf=|usr=007}} | ||
+ | {{tp|p=32458578|t=2020. COVID-19 encephalopathy masquerading as substance withdrawal.|pdf=|usr=007}} | ||
+ | {{tp|p=32453517|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.|pdf=|usr=007}} | ||
+ | {{tp|p=32453516|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32453515|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32497292|t=2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32432682|t=2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.|pdf=|usr=007}} | ||
+ | {{tp|p=32469387|t=2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.|pdf=|usr=007}} | ||
+ | {{tp|p=32497288|t=2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.|pdf=|usr=007}} | ||
+ | {{tp|p=32504746|t=2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.|pdf=|usr=007}} | ||
+ | {{tp|p=32427357|t=2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'|pdf=|usr=007}} | ||
+ | {{tp|p=32418237|t=2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".|pdf=|usr=007}} | ||
+ | {{tp|p=32484990|t=2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32451359|t=2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.|pdf=|usr=007}} | ||
+ | {{tp|p=32492193|t=2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32504100|t=2020. Ocular manifestations of coronavirus disease 2019.|pdf=|usr=007}} | ||
+ | {{tp|p=32437033|t=2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32437022|t=2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.|pdf=|usr=007}} | ||
+ | {{tp|p=32507468|t=2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.|pdf=|usr=007}} | ||
+ | {{tp|p=32461325|t=2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.|pdf=|usr=007}} | ||
+ | {{tp|p=32406374|t=2020. Olfactory dysfunction in the COVID-19 outbreak.|pdf=|usr=007}} | ||
+ | {{tp|p=32505878|t=2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.|pdf=|usr=007}} | ||
+ | {{tp|p=32412510|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32398625|t=2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.|pdf=|usr=007}} | ||
+ | {{tp|p=32505431|t=2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.|pdf=|usr=007}} | ||
+ | {{tp|p=32505432|t=2020. Does COVID-19 cause axonal GBS?|pdf=|usr=007}} | ||
+ | {{tp|p=32436835|t=2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.|pdf=|usr=007}} | ||
+ | {{tp|p=32408926|t=2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?|pdf=|usr=007}} | ||
+ | {{tp|p=32501751|t=2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32497397|t=2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32496658|t=2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32503820|t=2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32441248|t=2020. The impact of SARS-CoV-2 on sleep.|pdf=|usr=007}} | ||
+ | {{tp|p=32507123|t=2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32478675|t=2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32460415|t=2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?|pdf=|usr=007}} | ||
+ | {{tp|p=32433817|t=2020. Prolonged Confusional state as first manifestation of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32503088|t=2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.|pdf=|usr=007}} | ||
+ | {{tp|p=32503084|t=2020. Miller-Fisher syndrome after SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32503080|t=2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32492256|t=2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.|pdf=|usr=007}} | ||
+ | {{tp|p=32478936|t=2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.|pdf=|usr=007}} | ||
+ | {{tp|p=32450718|t=2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?|pdf=|usr=007}} | ||
+ | {{tp|p=32443166|t=2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).|pdf=|usr=007}} | ||
+ | {{tp|p=32449247|t=2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.|pdf=|usr=007}} | ||
+ | {{tp|p=32416028|t=2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.|pdf=|usr=007}} | ||
+ | {{tp|p=32468862|t=2020. L..: malignant MCA infarct in a patient with COVID 19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32463454|t=2020. Alterations in smell or taste - Classic COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32436625|t=2020. Low risk of SARS-CoV-2 transmission through the ocular surface.|pdf=|usr=007}} | ||
+ | {{tp|p=32484130|t=2020. COVID-19 associated central nervous system vasculopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32474587|t=2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.|pdf=|usr=007}} | ||
+ | {{tp|p=32491829|t=2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.|pdf=|usr=007}} | ||
+ | {{tp|p=32421258|t=2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.|pdf=|usr=007}} | ||
+ | {{tp|p=32403983|t=2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.|pdf=|usr=007}} | ||
+ | {{tp|p=32468972|t=2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32493536|t=2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32473022|t=2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.|pdf=|usr=007}} | ||
+ | {{tp|p=32420954|t=2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.|pdf=|usr=007}} | ||
+ | |||
+ | {{tp|p=32470238|t=2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.|pdf=|usr=007}} | ||
+ | |||
+ | |||
+ | {{tp|p=32467191|t=2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32467190|t=2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.|pdf=|usr=007}} | ||
+ | {{tp|p=32467189|t=2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.|pdf=|usr=007}} | ||
+ | {{tp|p=32439646|t=2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32409316|t=2020. Cerebrovascular Disease in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32354715|t=2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32483943|t=2020. Episcleritis as an ocular manifestation in a patient with COVID-19.|pdf=|usr=007}} |
Version vom 28. Juni 2020, 20:26 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
- Cerebral embolism
- Cerebral Haemorrhage
- Smell and taste disorder
- Brain infection Neurotropism
- Guillain-Barre Syndrome
- Autoimmune Neuropathies
- Neurology Reviews and Multitopic
- The morbid survivor late sequelae
32415003 2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?
32490972 2020. COVID-19 and the eye: how much do we really know? A best evidence review.
32443834 2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.
32348111 ä. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients? |
32322822 ä. THREE INSIGHTS ON PSYCHONEUROIMMUNOLOGY OF MOOD DISORDERS TO BE TAKEN FROM THE COVID-19 PANDEMIC
32328364 ä. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
32370982 ä. Ensuring mental health care during the SARS-CoV-2 epidemic in France: a narrative review
32363146 2020. COVID-19 Presenting with Seizures
32307298 ä. Severe cerebral involvement in adult-onset hemophagocytic lymphohistiocytosis
32232433 2020. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China
32344366 2020. Focal status epilepticus as unique clinical feature of COVID-19: A case report
32478706 2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?
32374367 ä. Delirium: a missing piece in the COVID-19 pandemic puzzle
32333819 2020. COVID-19: what if the brain had a role in causing the deaths?
32301553 2020. Lack of dyspnea in patients with Covid-19: another neurological conundrum? |
32246784 ä. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID?19 |
32246782 2020. Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2
32291797 2020. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration
32388138 2020. Hypothesized behavioral host manipulation by SARS-CoV2/COVID-19 infection |
32342265 ä. Coronavirus disease 2019 and obstructive sleep apnea syndrome
32457227 2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.
32390132 2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.
32482781 2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.
32461235 2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.
32444427 2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?
32386285 2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
32352450 2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.
32463395 2020. The involvement of the central nervous system in patients with COVID-19.
32355007 2020. The mystery of the pandemic's 'happy hypoxia'.
32286214 2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].
32400371 2020. [Anosmia and ageusia as primary symptoms of COVID-19].
32476394 2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.
32468632 2020. Olfactory dysfunction in recovered COVID-19 patients.
32512352 2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.
32442268 2020. Stroke in a young COVID -19 patient.
32484418 2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.
32437314 2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.
32437313 2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.
32407258 2020. COVID-19-Associated Leukoencephalopathy.
32510821 2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.
32506730 2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).
32506662 2020. Necrotizing periodontal disease: oral manifestation of COVID-19.
32419568 2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.
32453685 2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.
32490966 2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.
32469246 2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.
32436441 2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.
32423359 2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.
32423285 2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.
32502296 2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.
32502289 2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.
32348051 2020. Anosmie et COVID-19.
32501861 2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.
32404789 2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.
32468450 2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.
32444493 2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.
32444492 2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.
32439822 2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.
32439821 2020. Generalized myoclonus in COVID-19.
32487714 2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
32482845 2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
32424429 2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
32496534 2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.
32490520 2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.
32392566 2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack. |
32487282 2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.
32445201 2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.
32505222 2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
32503883 2020. Defining causality in COVID-19 and neurological disorders.
32507577 2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.
32458578 2020. COVID-19 encephalopathy masquerading as substance withdrawal.
32453517 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
32453516 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32453515 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32497292 2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.
32432682 2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.
32469387 2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
32497288 2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.
32504746 2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.
32427357 2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'
32418237 2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".
32484990 2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.
32451359 2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.
32492193 2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).
32504100 2020. Ocular manifestations of coronavirus disease 2019.
32437033 2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.
32437022 2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.
32507468 2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.
32461325 2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.
32406374 2020. Olfactory dysfunction in the COVID-19 outbreak.
32505878 2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
32412510 2020. Neurological manifestations of COVID-19.
32398625 2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.
32505431 2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.
32505432 2020. Does COVID-19 cause axonal GBS?
32436835 2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.
32408926 2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?
32501751 2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.
32497397 2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?
32496658 2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?
32503820 2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.
32441248 2020. The impact of SARS-CoV-2 on sleep.
32507123 2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.
32478675 2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).
32460415 2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?
32433817 2020. Prolonged Confusional state as first manifestation of COVID-19.
32503088 2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
32503084 2020. Miller-Fisher syndrome after SARS-CoV-2 infection.
32503080 2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.
32492256 2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.
32478936 2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.
32450718 2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?
32443166 2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).
32449247 2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.
32416028 2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.
32468862 2020. L..: malignant MCA infarct in a patient with COVID 19 infection.
32463454 2020. Alterations in smell or taste - Classic COVID-19?
32436625 2020. Low risk of SARS-CoV-2 transmission through the ocular surface.
32484130 2020. COVID-19 associated central nervous system vasculopathy.
32474587 2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.
32491829 2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.
32421258 2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.
32403983 2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.
32468972 2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.
32493536 2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.
32473022 2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.
32420954 2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.
32470238 2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.
32467191 2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.
32467190 2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.
32467189 2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.
32439646 2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.
32409316 2020. Cerebrovascular Disease in COVID-19.
32354715 2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.
32483943 2020. Episcleritis as an ocular manifestation in a patient with COVID-19.